Pharmaceutical - Asia-Pacific, Rest of the World


Popular Filters

Africa's pharmaceutical industry faces numerous challenges, VoA reports


Providing Africans with affordable health care could be realized if pharmaceutical products were produced…

Asia-PacificGenericsHealthcarePharmaceuticalProductionRest of the World

Hikma in-licenses inhaled insulin for MENA; Advaxis and FusionVax Asia deal


Jordan-based Hikma Pharmaceuticals (LSE: HIK) has signed a licensing and distribution agreement with…

AdvaxisADXS-HPVAsia-PacificDance 01Dance BiopharmDiabetesFusionVaxHikma PharmaceuticalsImmunologicalsLicensingOncologyPharmaceuticalRest of the World

Eisai launches Lunesta in Japan, debuts Zebinix in France; opens Dubai office


Japanese drug major Eisai (TYO: 4523) says it launched the insomnia treatment Lunesta (eszopiclone) in…

Asia-PacificEisaiEuropeLunestaMarkets & MarketingNeurologicalPharmaceuticalRest of the WorldZebinix

Back to top